Valuation: North China Pharmaceutical Company.Ltd

Market Cap 8.2B 1.23B 1.1B 1.01B 920M 1.74B 115B 1.79B 12.16B 4.84B 61.6B 4.61B 4.51B 195B P/E 2024
69.9x
P/E 2025 51.7x
Enterprise Value 17.88B 2.68B 2.4B 2.2B 2B 3.78B 251B 3.9B 26.5B 10.55B 134B 10.05B 9.83B 424B EV / Sales 2024
1.89x
EV / Sales 2025 2.07x
Free-Float
43.52%
Yield 2024
0.58%
Yield 2025 0.63%
1 day-1.65%
1 week+5.29%
Current month+5.05%
1 month-4.02%
3 months+0.42%
6 months-8.25%
Current year-13.56%
1 week 4.48
Extreme 4.48
4.86
1 month 4.43
Extreme 4.43
6.9
Current year 4.11
Extreme 4.11
6.9
1 year 4.11
Extreme 4.11
6.9
3 years 3.83
Extreme 3.83
7.46
5 years 3.83
Extreme 3.83
13.45
10 years 3.83
Extreme 3.83
20.24
Manager TitleAgeSince
Chief Executive Officer 55 28/11/2025
Director of Finance/CFO 46 10/04/2024
Investor Relations Contact 45 -
Director TitleAgeSince
Chairman 49 22/03/2016
Director/Board Member 53 23/04/2021
Director/Board Member 54 12/10/2022
Date Insider Type Main position Quantity % Market Cap. Importance
2/25/25 A Buy

Chairman

1,600 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%+5.29%-22.15%-19.80% 1.25B
-0.79%-1.43%+46.25%+138.46% 1,216B
+1.43%+0.37%+48.51%+82.52% 656B
+1.07%+0.18%+34.39%+105.99% 509B
-0.36%-2.84%+47.23%+64.51% 384B
-0.14%+0.27%+73.87%+41.93% 362B
-0.78%+0.59%+31.01%+59.68% 311B
-0.80%+6.73%+11.89%+35.64% 293B
+0.03%-0.07%+43.94%+70.61% 249B
-0.41%+0.77%+36.15%+104.55% 208B
Average -0.24%+0.80%+35.11%+68.41% 418.9B
Weighted average by Cap. -0.05%+0.04%+43.44%+91.82%

Financials

2024 2025
Net sales 9.87B 1.48B 1.33B 1.21B 1.11B 2.09B 139B 2.15B 14.63B 5.83B 74.14B 5.55B 5.43B 234B 9.24B 1.38B 1.24B 1.14B 1.04B 1.96B 130B 2.02B 13.7B 5.46B 69.42B 5.2B 5.08B 219B
Net income 127M 19.02M 17.08M 15.61M 14.24M 26.88M 1.79B 27.72M 188M 74.98M 954M 71.4M 69.87M 3.01B 183M 27.42M 24.62M 22.5M 20.53M 38.74M 2.57B 39.96M 271M 108M 1.38B 103M 101M 4.34B
Net Debt 9.79B 1.47B 1.32B 1.2B 1.1B 2.07B 138B 2.14B 14.51B 5.78B 73.54B 5.5B 5.39B 232B 9.67B 1.45B 1.3B 1.19B 1.08B 2.05B 136B 2.11B 14.34B 5.71B 72.67B 5.44B 5.32B 230B
Projected Income Statement - Annual - North China Pharmaceutical Company.Ltd
Logo North China Pharmaceutical Company.Ltd
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
9,972
Date Price Change Volume
06/11/26 CN¥4.780 -1.65% 42,728,582
05/11/26 CN¥4.860 +2.32% 60,087,322
04/11/26 CN¥4.750 +1.71% 57,414,259
03/11/26 CN¥4.670 +0.21% 54,622,350
02/11/26 CN¥4.660 +2.42% 51,412,705

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - North China Pharmaceutical Company.Ltd
  1. Stock Market
  2. Stocks
  3. 600812 Stock